Safety of Fentanyl TAIFUN Treatment

NCT00822614 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Breakthrough Cancer Pain

Interventions

DRUG: Fentanyl TAIFUN
DRUG: Opioid

Sponsor

Akela Pharma, Inc.